Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Chinese Journal of Lung Cancer
>
2023
>
26
>
9
Volume:
26
Issue:
9
1. A Novel Chinese Medicine Formula Inhibits Non-small Cell Lung Cancer by Triggering Oxidative Stress Dependent on Pentose Phosphate Pathway.
Page:639—649
2. Analysis of Clinicopathological Features on Spread Through Air Spaces of Lung Adenocarcinoma.
Page:650—658
3. Evaluation of Efficacy and Prognosis Analysis of Stage III-IV SMARCA4-deficient Non-small Cell Lung Cancer Treated by PD-1 Immune Checkpoint Inhibitors plus Chemotherapy and Chemotherapy.
Page:659—668
4. Identification of SULF1 as a Shared Gene in Idiopathic Pulmonary Fibrosis and Lung Adenocarcinoma.
Page:669—683
5. Drug Resistance Mechanism and Therapeutic Strategy of Targeted Therapy of Non-small Cell Lung Cancer with MET Alterations.
Page:684—691
6. Research Progress of Lung Cancer Vaccines.
Page:692—700
7. Research Advances of RAD51AP1 in Tumor Progression and Drug Resistance.
Page:701—708
8. Immune Checkpoint Inhibitors Related Cystoureteritis: A Case Report and Literature Review.
Page:709—716
9. Immune Thrombocytopenia Induced by Sintilimab in Lung Cancer: A Case Report and Literature Review.
Page:717—720